reverse transcriptase inhibitor
Quick Summary
A reverse transcriptase inhibitor is a type of antiviral drug used to treat infections caused by viruses like HIV. These drugs work by blocking the action of an enzyme called reverse transcriptase. HIV uses this enzyme to convert its RNA into DNA, a crucial step for its replication within host cells. By inhibiting reverse transcriptase, these drugs prevent the virus from making copies of itself.
AZT, a nucleoside reverse transcriptase inhibitor (NRTI), was the first such drug approved to slow the progression of HIV infection and delay the development of AIDS. While effective, HIV can develop resistance, so these inhibitors are often used in combination with other antiretroviral drugs, such as protease inhibitors, to enhance treatment efficacy and combat drug resistance.
Ask Britannica AI about this topic
Britannica doesn't have a full article on this topic, so we've curated a list of our relevant coverage.
- protease inhibitor
…inhibitor in combination with a reverse transcriptase inhibitor, which blocks the conversion of retroviral RNA into DNA, suppresses HIV replication better than either drug alone. The most effective combination therapy used to suppress the emergence of resistant virus is highly active antiretroviral therapy (HAART), which combines three or more reverse…
Read More…inhibitor in combination with a reverse transcriptase inhibitor, which blocks the conversion of retroviral RNA into DNA, suppresses HIV replication better than either drug alone. The most effective combination therapy used to suppress the emergence of resistant virus is highly active antiretroviral therapy (HAART), which combines three or more reverse…
Read More 
antiviral drugAnti-HIV drugsReverse transcriptase (RT) inhibitors work by blocking the action of reverse transcriptase. There are two groups of RT inhibitors. Nucleoside RT inhibitors (e.g., zidovudine, didanosine, zalcitabine, lamivudine, and stavudine) must be phosphorylated to become active. These drugs mimic the normal nucleosides and block reverse transcriptase.…
Read MoreReverse transcriptase (RT) inhibitors work by blocking the action of reverse transcriptase. There are two groups of RT inhibitors. Nucleoside RT inhibitors (e.g., zidovudine, didanosine, zalcitabine, lamivudine, and stavudine) must be phosphorylated to become active. These drugs mimic the normal nucleosides and block reverse transcriptase.…
Read More